Intended for healthcare professionals


Sixty seconds on . . . psilocybin

BMJ 2016; 353 doi: (Published 18 May 2016) Cite this as: BMJ 2016;353:i2775
  1. Nigel Hawkes
  1. London

Shades of Aldous Huxley and Timothy Leary—are magic mushrooms back on the menu?

Not so fast. There’s a long way to go. But a study in London has shown that the active ingredient in magic mushrooms, psilocybin, may be effective against treatment resistant depression. Its effects were quick—within a week—and more than 40% of the patients treated were still in remission three months later.1

Good news, surely?

Yes, as far as it goes. These were people whose depression had …

View Full Text

Log in

Log in through your institution


* For online subscription